PSIAC

Literaturverzeichnis


Yin OQ. J Clin Psychopharmacol. Aug 2006; 26(4): 367-72 Pubmed [94]
Yin OQ. Pharmacogenetics. Dec 2004; 14(12): 841-50 Pubmed [401]
Yin WJ. J Am Heart Assoc. Feb 2017; 6(2) Pubmed [4916]
Yisak W et al. Acta Psychiatr Scand (1990) 82 (Suppl 358), 58-62 [687]
Yokochi K. Ther Drug Monit. Jan 1982; 4(4): 353-7 Pubmed [2089]
Yorbik O. Ther Drug Monit. Jun 2015; 37(3): 347-52 Pubmed [4954]
Yoshida et al. (2007) Pharmacopsychiatry 82-83 [2576]
Yoshii K. Life Sci. Jan 2000; 67(2): 175-84 Pubmed [89]
Yoshimoto K. Br J Clin Pharmacol. Apr 1995; 39(4): 421-31 Pubmed, Volltext [3286]
Yoshinari K. Biochem Pharmacol. Jul 2008; 76(1): 139-45 Pubmed [1176]
Yoshizato T. Eur J Clin Pharmacol. Sep 2012; 68(9): 1287-94 Pubmed [4099]
Yosselson-Superstine S. Ann Intern Med. Feb 1982; 96(2): 259-60 Pubmed [794]
Young A. Br J Psychiatry. May 1989; 154: 710-2 Pubmed [865]
Young D. Eur J Clin Pharmacol. Jan 1993; 44(5): 433-8 Pubmed [1524]
Young MC. Clin Toxicol (Phila). Jul 2009; 47(6): 580-3 Pubmed [590]
Youssef MS. Anaesthesia. Mar 1988; 43(3): 210-2 Pubmed [2361]
Ytterberg C. Acta Neurol Scand. Aug 2007; 116(2): 96-9 Pubmed [3880]
Yu BN. Drug Metab Dispos. Oct 2003; 31(10): 1255-9 Pubmed [3062]
Yu J. Drug Metab Dispos. Dec 2014; 42(12): 1991-2001 Pubmed [4441]
Yu KS. Clin Pharmacol Ther. Apr 2001; 69(4): 266-73 Pubmed [2785]
Yu LJ. J Pharmacol Exp Ther. Mar 1999; 288(3): 928-37 Pubmed [3055]
Yuan et al. J Clin Pharmacol 1999;39:1109-1125 [1860]
Yuan R. J Clin Pharmacol. Nov 1999; 39(11): 1109-25 Pubmed [486]
Yue QY. Eur J Clin Pharmacol. Jan 1997; 52(1): 41-7 Pubmed [4379]
Yue QY. Lancet. Feb 2000; 355(9203): 576-7 Pubmed [1571]
Yue QY. Pharmacogenetics. Aug 1994; 4(4): 193-8 Pubmed [725]
Yuen GJ. Clin Pharmacokinet. Jan 2008; 47(6): 351-71 Pubmed [5051]
Yukawa et al. J Clin Psychopharmacol (1985) 19, 588-93 [1042]
Yun CH. Anesthesiology. Sep 1992; 77(3): 467-74 Pubmed [26]
Zaccara G. Ther Drug Monit. Feb 1993; 15(1): 39-42 Pubmed [1995]
Zadoyan et al. Eur J Clin Pharmacol E-pub ahead [3350]
Zadoyan G. Eur J Clin Pharmacol. May 2012; 68(5): 553-60 Pubmed, Volltext, Springer [1123]
Zadoyan G. Planta Med. Sep 2012; 78(13): 1428-57 Pubmed [1126]
Zakharyants AA. Bull Exp Biol Med. Feb 2017; 162(4): 515-519 Pubmed [4466]
Zalma A. Biol Psychiatry. Apr 2000; 47(7): 655-61 Pubmed [4317]
Zanettini C. Eur J Pharmacol. Jan 2014; 723: 405-9 Pubmed [5098]
Zanidip (Lerancidipine). Napp Parmaceuticals Limited [1882]
Zanidip (Lercanidipine). Napp Pharmaceuticals Limited. Summary of Product Characteristics, March 2001 [745]
Zelman S, Guillan R. Heat stroke in phenothiazine-treated patients: a reprot of three fatalities [952]
Zelman S. Am J Psychiatry. Jun 1970; 126(12): 1787-90 Pubmed [664]
Zeneca Pharma. Personal communication, October 1997 [2203]
Zeng JZ. Eur J Clin Invest. Dec 1983; 13(6): 475-9 Pubmed [1014]
Zeng Z. Xenobiotica. Mar 1998; 28(3): 313-21 Pubmed [5039]
Zeni CP. J Child Adolesc Psychopharmacol. Oct 2009; 19(5): 553-61 Pubmed [4953]
Zerjav-Lacombe S. Ann Pharmacother. Feb 2001; 35(2): 180-2 Pubmed [3726]
Zevin S. Clin Pharmacokinet. Jun 1999; 36(6): 425-38 Pubmed [2737]
Zhang D. Drug Metab Dispos. Apr 2013; 41(4): 827-35 Pubmed [319]
Zhang D. Drug Metab Dispos. Dec 2007; 35(12): 2270-80 Pubmed [4696]
Zhang H. Clin Pharmacokinet. Jan 2007; 46(2): 133-57 Pubmed [4694]
Zhang J. J Clin Psychiatry. Jan 2015; 76(1): 8-14 Pubmed [4058]
Zhang JG. Drug Metab Dispos. Sep 2014; 42(9): 1379-91 Pubmed [3869]
Zhang JW. Drug Metab Dispos. Nov 2008; 36(11): 2292-8 Pubmed [3652]
Zhang JW. Eur J Clin Pharmacol. Jul 2006; 62(7): 497-502 Pubmed [2485]
Zhang L. Acta Pharmacol Sin. Dec 2008; 29(12): 1507-14 Pubmed [3151]
Zhang S. Xenobiotica. May 2012; 42(5): 409-16 Pubmed [3283]
Zhang T. Eur J Pharm Sci. Sep 2015; 77: 216-29 Pubmed [4054]
Zhang W. Clin Pharmacokinet. Sep 2017; 56(9): 1033-1043 Pubmed [4998]
Zhang W. Drug Metab Dispos. Jun 2003; 31(6): 768-72 Pubmed [328]
Zhang YT. Br J Clin Pharmacol. Aug 2008; 66(2): 240-6 Pubmed, Volltext, DOI [4340]
Zhao XJ. Br J Clin Pharmacol. Nov 1997; 44(5): 505-11 Pubmed, Volltext, DOI [3288]
Zhao XJ. Eur J Drug Metab Pharmacokinet. Jul 1999; 24(3): 272-8 Pubmed [4771]
Zhao XJ. Xenobiotica. Oct 2002; 32(10): 863-78 Pubmed [439]
Zhi J. J Clin Pharmacol. Sep 2002; 42(9): 1011-9 Pubmed [3209]
Zhou D. Drug Metab Dispos. May 2010; 38(5): 863-70 Pubmed [4986]
Zhou HH. Clin Pharmacol Ther. Jun 1990; 47(6): 686-93 Pubmed [4184]
Zhou SF. Clin Pharmacokinet. Jan 2009; 48(12): 761-804 Pubmed [125]
Zhou SF. Curr Drug Metab. Jun 2008; 9(5): 394-409 Pubmed [2850]
Zhou SF. Curr Med Chem. Jan 2009; 16(27): 3480-675 Pubmed [2113]
Zhou SF. Ther Drug Monit. Dec 2007; 29(6): 687-710 Pubmed [2650]
Zhou WJ. Br J Pharmacol. Jul 2012; 166(5): 1669-83 Pubmed, Volltext, DOI [4404]
Zhou YT. Ther Clin Risk Manag. Jan 2014; 10: 17-26 Pubmed, Volltext, DOI [4146]
Zhou-Pan XR. Cancer Res. Nov 1993; 53(21): 5121-6 Pubmed [4835]
Zhu M. Antimicrob Agents Chemother. Jun 2009; 53(6): 2346-53 Pubmed, Volltext, DOI [3039]
Zimmer R. Acta Psychiatr Scand Suppl. Jan 1990; 360: 84-6 Pubmed [1926]
Zimmerman HJ. Hepatology. Sep 1995; 22(3): 767-73 Pubmed [3503]
Zirkle GA, King PD, McAtee OB, Van Dyke R. Effects of chlorpromazine and alcohol on coordination and judgment. JAMA (1959) 171, 1496-9 [817]
Zo'o M. Pediatr Radiol. Nov 2011; 41(11): 1393-400 Pubmed [4918]
Zoccali et al. (2007) J Clin Psychopharmacol 93:109-116 [1144]
Zoccali R. Pharmacol Res. Oct 2003; 48(4): 411-4 Pubmed [2545]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics, Novembet 2001 [2504]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics. November 2001 [2078]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics., November 2001 [1646]
Zoleptil (Zotepine) Knoll Limited . Summary of product characteristics., Novembet 2001 [945]
Zoleptil (Zotepine). Knoll Limited. Summary of product characteristics, November 2001 [2515]
Zubieta, Demitrack. J Clin Pharmacol (1991) 11, 327-328 [1336]
Zullino DF. Drugs Today (Barc). Jul 2004; 40(7): 603-19 Pubmed [4174]
Zullino DF. Int Clin Psychopharmacol. May 2002; 17(3): 141-3 Pubmed [1193]
Zumoff B. JAMA. May 1977; 237(18): 1960-1 Pubmed [792]
Zusammenfassung der zur Zulassung eingereichten Klinischen Studien: ZHANG, J: FDA Clinical Review of Olanzapine Pamoate Depot in the Treatment of Schizophrenie: http://www.fda.gov/ohrms/dockets/AC/08/slides/2008-4338s1-01-FDA-Zhang_files/frames.htm [3029]
Zwanzger P. J Clin Psychiatry. Mar 2001; 62(3): 208-9 Pubmed [1672]
Zweers-Zeilmaker WM. Xenobiotica. Aug 1997; 27(8): 769-80 Pubmed [4510]